Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of KYORIN Pharmaceutical Co., Ltd.. A complete text table follows the diagram.
The filing shows JPY58.7 billion of revenue, JPY1.36 billion of operating profit and JPY5.44 billion of R&D before securities gains and subsidy income.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Cost of sales | 1 | 33.8B | 59.0% of reported total |
| Selling, general and administrative | 1 | 23.5B | 41.0% of reported total |
| Operating costs | 2 | 57.4B | Cost of sales and selling, general and administrative expenses |
| Operating profit | 3 | 1.4B | 2.4% operating margin |
| Operating costs & expenses | 3 | 56.0B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 2.0B | Reported pretax result |
| Operating profit | 3 | 666M | Gross profit of JPY24,896 million leaves JPY1,363 million of operating profit after JPY23,532 million of SG&A, including JPY5,443 million of R&D. |
| Net profit attributable to owners | 5 | 1.5B | Reported parent-company result |
| Tax, attribution & other | 5 | 535M | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Cost of sales | Operating costs | 33.8B |
| Selling, general and administrative | Operating costs | 23.5B |
| Operating costs | Operating profit | 1.4B |
| Operating costs | Operating costs & expenses | 56.0B |
| Operating profit | Profit before tax | 1.4B |
| Operating profit | Profit before tax | 666M |
| Profit before tax | Net profit attributable to owners | 1.5B |
| Profit before tax | Tax, attribution & other | 535M |